CASI Pharmaceuticals, Inc. Share Price Nasdaq
Stocks
CASI
KYG1933S1012
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1317 USD | -34.13% |
|
-22.53% | -84.51% |
| Market Cap | 2.71M 2.37M 2.18M 2.02M 3.84M 257M 3.9M 26.18M 10.18M 127M 10.16M 9.94M 438M | P/E 2026 * |
-0.09x | P/E 2027 * | -0.09x |
|---|---|---|---|---|---|
| Enterprise Value | 2.71M 2.37M 2.18M 2.02M 3.84M 257M 3.9M 26.18M 10.18M 127M 10.16M 9.94M 438M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
53.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -22.53% | ||
| Current month | -22.53% | ||
| 1 month | +1.31% | ||
| 3 months | -12.43% | ||
| 6 months | -84.76% | ||
| Current year | -84.51% |
| 1 week | 0.12 |  | 0.25 |
| 1 month | 0.1 | | 0.35 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.4 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 20/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 15/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 31/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 31/03/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 20/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 20/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.13% | -22.53% | -90.09% | -94.97% | 2.71M | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 336B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 288B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 222B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 137B | |
| Average | +0.85% | +2.00% | +15.24% | +38.63% | 393.9B | |
| Weighted average by Cap. | +1.51% | +1.86% | +41.96% | +87.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -24.73M -21.64M -19.94M -18.48M -35.09M -2.35B -35.65M -239M -92.99M -1.16B -92.83M -90.82M -4B | -26.51M -23.2M -21.38M -19.82M -37.62M -2.52B -38.22M -256M -99.7M -1.24B -99.53M -97.37M -4.29B |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | US$0.1317 | -34.13% | 190 |
| 06/07/26 | US$0.1999 | +36.11% | 800 |
| 02/07/26 | US$0.1469 | -38.79% | 3,966 |
| 01/07/26 | US$0.2400 | +41.18% | 26,575 |
| 30/06/26 | US$0.1700 | +38.21% | 1,763 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1317USD
Average target price
4.000USD
Spread / Average Target
+2,937.21%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASI.F Stock
- CASI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
